vimarsana.com
Home
Live Updates
GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targe
GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targe
GT Biopharma Abstract on Novel B7-H3 Immune Checkpoint Targeting Broad Spectrum Solid and Hematologic Malignancies Accepted for Presentation at ESMO IO Congress 2021
ESMO-IO will publish full abstracts on their website on Thursday, December 2 at 12:00 pm CET . GT Biopharma will post its poster on the company's website in the "Presentations" section during the conference.
Related Keywords
Switzerland ,
Beverly Hills ,
Exchange Commission ,
University Of Minnesota ,
Gt Biopharma Inc ,
European Society For Medical Oncology ,
Oncology Io Congress ,
European Society ,
Medical Oncology ,
Poster Display Title ,
Tri Specific Killer Engager ,
Annual Report ,
Quarterly Report ,
Securities Act ,
Cancer ,
Congress ,
Forward Looking Statement ,
Genetic Engineering ,
Immune System ,
Immunology ,
Medical Specialties ,
Therapeutics ,
Antibody ,
Branches Of Biology ,
Cancer Immunotherapy ,
Natural Killer Cell ,
Single Domain Antibody ,